stockrowNovoCure Limited (NVCR) vs TransMedics Group, Inc. (TMDX)
- NovoCure Limited NVCR 13.47 −0.59%
- TransMedics Group, Inc. TMDX 85.47 +23.91%
NovoCure Limited and TransMedics Group, Inc. are both Medical Devices companies. TransMedics Group, Inc. is the larger, with a market value of $2.4B against $1.6B — 1.5× the size. NovoCure Limited has negative trailing earnings, so its P/E is not meaningful; TransMedics Group, Inc. trades at 16.4×. TransMedics Group, Inc. grew revenue faster over the last twelve months: 28.5% against 12.9%. TransMedics Group, Inc. has the higher net margin (19.9% vs −16.8%) and the higher return on invested capital (48.0% vs −106.1%). Across the 18 metrics below, TransMedics Group, Inc. leads on 15 and NovoCure Limited on 3.
Valuation
Profitability
| Metric | NVCR | TMDX | Medical Devices median |
|---|---|---|---|
| Gross margin | 77.02% | 58.60% | 57.76% |
| Operating margin | (17.17%) | 11.88% | (15.07%) |
| Net margin | (16.78%) | 19.85% | (14.45%) |
| Free cash flow margin | (3.39%) | 6.14% | (3.88%) |
| Return on equity | (35.18%) | 31.89% | (10.35%) |
| Return on assets | (11.12%) | 11.73% | (17.26%) |
| Return on invested capital | (106.10%) | 48.00% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack